nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Ifosfamide—germ cell cancer	0.146	0.436	CbGbCtD
Trametinib—CYP2C8—Etoposide—germ cell cancer	0.0698	0.208	CbGbCtD
Trametinib—CYP3A4—Ifosfamide—germ cell cancer	0.0593	0.177	CbGbCtD
Trametinib—CYP3A4—Vinblastine—germ cell cancer	0.0314	0.0939	CbGbCtD
Trametinib—CYP3A4—Etoposide—germ cell cancer	0.0283	0.0845	CbGbCtD
Trametinib—MAP2K1—neck—germ cell cancer	0.00689	0.0526	CbGeAlD
Trametinib—MAP2K1—embryo—germ cell cancer	0.00575	0.0438	CbGeAlD
Trametinib—MAP2K1—brainstem—germ cell cancer	0.00526	0.0402	CbGeAlD
Trametinib—MAP2K2—trigeminal ganglion—germ cell cancer	0.00524	0.04	CbGeAlD
Trametinib—MAP2K1—eye—germ cell cancer	0.00513	0.0391	CbGeAlD
Trametinib—MAP2K1—telencephalon—germ cell cancer	0.00467	0.0356	CbGeAlD
Trametinib—MAP2K1—skin of body—germ cell cancer	0.00446	0.034	CbGeAlD
Trametinib—MAP2K2—telencephalon—germ cell cancer	0.00411	0.0314	CbGeAlD
Trametinib—MAP2K2—skin of body—germ cell cancer	0.00393	0.0299	CbGeAlD
Trametinib—MAP2K1—gonad—germ cell cancer	0.0039	0.0297	CbGeAlD
Trametinib—MAP2K2—decidua—germ cell cancer	0.0039	0.0297	CbGeAlD
Trametinib—CYP3A4—urine—germ cell cancer	0.00367	0.028	CbGeAlD
Trametinib—MAP2K2—gonad—germ cell cancer	0.00343	0.0262	CbGeAlD
Trametinib—MAP2K2—uterus—germ cell cancer	0.00341	0.026	CbGeAlD
Trametinib—MAP2K1—adrenal gland—germ cell cancer	0.0034	0.0259	CbGeAlD
Trametinib—MAP2K2—pituitary gland—germ cell cancer	0.00335	0.0255	CbGeAlD
Trametinib—MAP2K1—bone marrow—germ cell cancer	0.00329	0.0251	CbGeAlD
Trametinib—MAP2K1—spinal cord—germ cell cancer	0.00327	0.025	CbGeAlD
Trametinib—MAP2K2—medulla oblongata—germ cell cancer	0.00323	0.0247	CbGeAlD
Trametinib—MAP2K1—female gonad—germ cell cancer	0.00317	0.0242	CbGeAlD
Trametinib—MAP2K2—adrenal gland—germ cell cancer	0.00299	0.0228	CbGeAlD
Trametinib—MAP2K2—midbrain—germ cell cancer	0.00295	0.0225	CbGeAlD
Trametinib—MAP2K1—endocrine gland—germ cell cancer	0.00295	0.0225	CbGeAlD
Trametinib—MAP2K1—head—germ cell cancer	0.00291	0.0222	CbGeAlD
Trametinib—MAP2K2—bone marrow—germ cell cancer	0.00289	0.0221	CbGeAlD
Trametinib—MAP2K2—spinal cord—germ cell cancer	0.00288	0.022	CbGeAlD
Trametinib—MAP2K1—testis—germ cell cancer	0.00281	0.0214	CbGeAlD
Trametinib—MAP2K2—female gonad—germ cell cancer	0.00279	0.0213	CbGeAlD
Trametinib—MAP2K1—cerebellum—germ cell cancer	0.0026	0.0198	CbGeAlD
Trametinib—MAP2K2—endocrine gland—germ cell cancer	0.00259	0.0198	CbGeAlD
Trametinib—MAP2K2—head—germ cell cancer	0.00256	0.0195	CbGeAlD
Trametinib—MAP2K2—testis—germ cell cancer	0.00247	0.0189	CbGeAlD
Trametinib—MAP2K2—cerebellum—germ cell cancer	0.00229	0.0174	CbGeAlD
Trametinib—MAP2K1—brain—germ cell cancer	0.00211	0.0161	CbGeAlD
Trametinib—MAP2K1—lymph node—germ cell cancer	0.00204	0.0155	CbGeAlD
Trametinib—MAP2K2—brain—germ cell cancer	0.00186	0.0142	CbGeAlD
Trametinib—MAP2K2—lymph node—germ cell cancer	0.00179	0.0137	CbGeAlD
Trametinib—CYP2C8—pituitary gland—germ cell cancer	0.00116	0.00885	CbGeAlD
Trametinib—Neutropenia—Dactinomycin—germ cell cancer	0.0011	0.0036	CcSEcCtD
Trametinib—Stomatitis—Bleomycin—germ cell cancer	0.0011	0.00359	CcSEcCtD
Trametinib—Cardiac failure congestive—Etoposide—germ cell cancer	0.00109	0.00356	CcSEcCtD
Trametinib—Hyponatraemia—Cisplatin—germ cell cancer	0.00108	0.00353	CcSEcCtD
Trametinib—Haematuria—Bleomycin—germ cell cancer	0.00107	0.00351	CcSEcCtD
Trametinib—Pancreatitis—Ifosfamide—germ cell cancer	0.00106	0.00346	CcSEcCtD
Trametinib—Stomatitis—Dactinomycin—germ cell cancer	0.00102	0.00335	CcSEcCtD
Trametinib—Haemoglobin—Bleomycin—germ cell cancer	0.00102	0.00332	CcSEcCtD
Trametinib—Haemorrhage—Bleomycin—germ cell cancer	0.00101	0.0033	CcSEcCtD
Trametinib—Blood creatinine increased—Cisplatin—germ cell cancer	0.00101	0.0033	CcSEcCtD
Trametinib—Dehydration—Cisplatin—germ cell cancer	0.001	0.00327	CcSEcCtD
Trametinib—Hypokalaemia—Cisplatin—germ cell cancer	0.000979	0.0032	CcSEcCtD
Trametinib—Hyperglycaemia—Ifosfamide—germ cell cancer	0.000973	0.00318	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.000969	0.00317	CcSEcCtD
Trametinib—Anaemia—Vinblastine—germ cell cancer	0.000962	0.00315	CcSEcCtD
Trametinib—Infestation NOS—Ifosfamide—germ cell cancer	0.000962	0.00315	CcSEcCtD
Trametinib—Infestation—Ifosfamide—germ cell cancer	0.000962	0.00315	CcSEcCtD
Trametinib—Renal failure—Ifosfamide—germ cell cancer	0.000945	0.00309	CcSEcCtD
Trametinib—Stomatitis—Ifosfamide—germ cell cancer	0.000937	0.00307	CcSEcCtD
Trametinib—Leukopenia—Vinblastine—germ cell cancer	0.000932	0.00305	CcSEcCtD
Trametinib—Haematuria—Ifosfamide—germ cell cancer	0.000917	0.003	CcSEcCtD
Trametinib—Pancreatitis—Cisplatin—germ cell cancer	0.000912	0.00298	CcSEcCtD
Trametinib—Chills—Bleomycin—germ cell cancer	0.000906	0.00296	CcSEcCtD
Trametinib—Bone disorder—Methotrexate—germ cell cancer	0.0009	0.00295	CcSEcCtD
Trametinib—Hypertension—Vinblastine—germ cell cancer	0.000899	0.00294	CcSEcCtD
Trametinib—CYP2C8—endocrine gland—germ cell cancer	0.000899	0.00685	CbGeAlD
Trametinib—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.000894	0.00293	CcSEcCtD
Trametinib—Abdominal discomfort—Cisplatin—germ cell cancer	0.000891	0.00292	CcSEcCtD
Trametinib—Erythema—Bleomycin—germ cell cancer	0.000879	0.00288	CcSEcCtD
Trametinib—Bradycardia—Ifosfamide—germ cell cancer	0.000879	0.00287	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000869	0.00284	CcSEcCtD
Trametinib—Haemoglobin—Ifosfamide—germ cell cancer	0.000868	0.00284	CcSEcCtD
Trametinib—Haemorrhage—Ifosfamide—germ cell cancer	0.000863	0.00282	CcSEcCtD
Trametinib—CYP2C8—testis—germ cell cancer	0.000857	0.00654	CbGeAlD
Trametinib—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000852	0.00279	CcSEcCtD
Trametinib—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000848	0.00278	CcSEcCtD
Trametinib—Urethral disorder—Ifosfamide—germ cell cancer	0.000846	0.00277	CcSEcCtD
Trametinib—Chills—Dactinomycin—germ cell cancer	0.000845	0.00277	CcSEcCtD
Trametinib—Thrombocytopenia—Vinblastine—germ cell cancer	0.000832	0.00272	CcSEcCtD
Trametinib—Erythema—Dactinomycin—germ cell cancer	0.00082	0.00268	CcSEcCtD
Trametinib—Renal failure—Cisplatin—germ cell cancer	0.000815	0.00267	CcSEcCtD
Trametinib—Anaemia—Bleomycin—germ cell cancer	0.000813	0.00266	CcSEcCtD
Trametinib—Stomatitis—Cisplatin—germ cell cancer	0.000808	0.00264	CcSEcCtD
Trametinib—Eye disorder—Ifosfamide—germ cell cancer	0.000807	0.00264	CcSEcCtD
Trametinib—Cardiac disorder—Ifosfamide—germ cell cancer	0.000801	0.00262	CcSEcCtD
Trametinib—Neutropenia—Etoposide—germ cell cancer	0.000796	0.00261	CcSEcCtD
Trametinib—Melaena—Methotrexate—germ cell cancer	0.000794	0.0026	CcSEcCtD
Trametinib—Leukopenia—Bleomycin—germ cell cancer	0.000787	0.00257	CcSEcCtD
Trametinib—Angiopathy—Ifosfamide—germ cell cancer	0.000783	0.00256	CcSEcCtD
Trametinib—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000778	0.00255	CcSEcCtD
Trametinib—Chills—Ifosfamide—germ cell cancer	0.000775	0.00253	CcSEcCtD
Trametinib—Arrhythmia—Ifosfamide—germ cell cancer	0.000771	0.00252	CcSEcCtD
Trametinib—Cough—Bleomycin—germ cell cancer	0.000767	0.00251	CcSEcCtD
Trametinib—Infestation NOS—Etoposide—germ cell cancer	0.000759	0.00248	CcSEcCtD
Trametinib—Infestation—Etoposide—germ cell cancer	0.000759	0.00248	CcSEcCtD
Trametinib—Anaemia—Dactinomycin—germ cell cancer	0.000758	0.00248	CcSEcCtD
Trametinib—Bradycardia—Cisplatin—germ cell cancer	0.000758	0.00248	CcSEcCtD
Trametinib—Mental disorder—Ifosfamide—germ cell cancer	0.000756	0.00247	CcSEcCtD
Trametinib—Erythema—Ifosfamide—germ cell cancer	0.000751	0.00246	CcSEcCtD
Trametinib—Malnutrition—Ifosfamide—germ cell cancer	0.000751	0.00246	CcSEcCtD
Trametinib—Myalgia—Bleomycin—germ cell cancer	0.000749	0.00245	CcSEcCtD
Trametinib—Renal failure—Etoposide—germ cell cancer	0.000747	0.00244	CcSEcCtD
Trametinib—Stomatitis—Etoposide—germ cell cancer	0.00074	0.00242	CcSEcCtD
Trametinib—Decreased appetite—Vinblastine—germ cell cancer	0.000739	0.00242	CcSEcCtD
Trametinib—Mouth ulceration—Methotrexate—germ cell cancer	0.000735	0.00241	CcSEcCtD
Trametinib—Neoplasm—Methotrexate—germ cell cancer	0.000735	0.00241	CcSEcCtD
Trametinib—Urinary tract disorder—Cisplatin—germ cell cancer	0.000735	0.0024	CcSEcCtD
Trametinib—Leukopenia—Dactinomycin—germ cell cancer	0.000734	0.0024	CcSEcCtD
Trametinib—Connective tissue disorder—Cisplatin—germ cell cancer	0.000731	0.00239	CcSEcCtD
Trametinib—Urethral disorder—Cisplatin—germ cell cancer	0.000729	0.00239	CcSEcCtD
Trametinib—Constipation—Vinblastine—germ cell cancer	0.000727	0.00238	CcSEcCtD
Trametinib—Oedema—Bleomycin—germ cell cancer	0.000718	0.00235	CcSEcCtD
Trametinib—Infection—Bleomycin—germ cell cancer	0.000713	0.00233	CcSEcCtD
Trametinib—Vision blurred—Ifosfamide—germ cell cancer	0.000708	0.00232	CcSEcCtD
Trametinib—Thrombocytopenia—Bleomycin—germ cell cancer	0.000703	0.0023	CcSEcCtD
Trametinib—Myalgia—Dactinomycin—germ cell cancer	0.000698	0.00228	CcSEcCtD
Trametinib—Eye disorder—Cisplatin—germ cell cancer	0.000695	0.00228	CcSEcCtD
Trametinib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000695	0.00227	CcSEcCtD
Trametinib—Anaemia—Ifosfamide—germ cell cancer	0.000695	0.00227	CcSEcCtD
Trametinib—Cardiac disorder—Cisplatin—germ cell cancer	0.000691	0.00226	CcSEcCtD
Trametinib—Urinary tract disorder—Etoposide—germ cell cancer	0.000673	0.0022	CcSEcCtD
Trametinib—Leukopenia—Ifosfamide—germ cell cancer	0.000673	0.0022	CcSEcCtD
Trametinib—Abdominal pain—Vinblastine—germ cell cancer	0.000672	0.0022	CcSEcCtD
Trametinib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000671	0.00219	CcSEcCtD
Trametinib—Oedema—Dactinomycin—germ cell cancer	0.000669	0.00219	CcSEcCtD
Trametinib—Urethral disorder—Etoposide—germ cell cancer	0.000668	0.00219	CcSEcCtD
Trametinib—Infection—Dactinomycin—germ cell cancer	0.000665	0.00218	CcSEcCtD
Trametinib—Arrhythmia—Cisplatin—germ cell cancer	0.000665	0.00217	CcSEcCtD
Trametinib—Cough—Ifosfamide—germ cell cancer	0.000656	0.00215	CcSEcCtD
Trametinib—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000655	0.00214	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000654	0.00214	CcSEcCtD
Trametinib—Hypertension—Ifosfamide—germ cell cancer	0.000649	0.00212	CcSEcCtD
Trametinib—Erythema—Cisplatin—germ cell cancer	0.000648	0.00212	CcSEcCtD
Trametinib—Malnutrition—Cisplatin—germ cell cancer	0.000648	0.00212	CcSEcCtD
Trametinib—CYP2C8—brain—germ cell cancer	0.000643	0.0049	CbGeAlD
Trametinib—Arthralgia—Ifosfamide—germ cell cancer	0.00064	0.00209	CcSEcCtD
Trametinib—Myalgia—Ifosfamide—germ cell cancer	0.00064	0.00209	CcSEcCtD
Trametinib—Renal failure acute—Methotrexate—germ cell cancer	0.000639	0.00209	CcSEcCtD
Trametinib—Eye disorder—Etoposide—germ cell cancer	0.000637	0.00208	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000635	0.00208	CcSEcCtD
Trametinib—Cardiac disorder—Etoposide—germ cell cancer	0.000633	0.00207	CcSEcCtD
Trametinib—Decreased appetite—Bleomycin—germ cell cancer	0.000624	0.00204	CcSEcCtD
Trametinib—Muscle spasms—Cisplatin—germ cell cancer	0.000623	0.00204	CcSEcCtD
Trametinib—Angiopathy—Etoposide—germ cell cancer	0.000619	0.00202	CcSEcCtD
Trametinib—Mediastinal disorder—Etoposide—germ cell cancer	0.000614	0.00201	CcSEcCtD
Trametinib—Oedema—Ifosfamide—germ cell cancer	0.000613	0.00201	CcSEcCtD
Trametinib—Chills—Etoposide—germ cell cancer	0.000612	0.002	CcSEcCtD
Trametinib—Vision blurred—Cisplatin—germ cell cancer	0.000611	0.002	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00061	0.00199	CcSEcCtD
Trametinib—Asthenia—Vinblastine—germ cell cancer	0.00061	0.00199	CcSEcCtD
Trametinib—Infection—Ifosfamide—germ cell cancer	0.000609	0.00199	CcSEcCtD
Trametinib—CYP3A4—endocrine gland—germ cell cancer	0.000609	0.00464	CbGeAlD
Trametinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000601	0.00197	CcSEcCtD
Trametinib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.0006	0.00196	CcSEcCtD
Trametinib—Anaemia—Cisplatin—germ cell cancer	0.000599	0.00196	CcSEcCtD
Trametinib—Skin disorder—Ifosfamide—germ cell cancer	0.000596	0.00195	CcSEcCtD
Trametinib—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000593	0.00194	CcSEcCtD
Trametinib—Decreased appetite—Dactinomycin—germ cell cancer	0.000582	0.0019	CcSEcCtD
Trametinib—Diarrhoea—Vinblastine—germ cell cancer	0.000581	0.0019	CcSEcCtD
Trametinib—Dysgeusia—Etoposide—germ cell cancer	0.000581	0.0019	CcSEcCtD
Trametinib—Leukopenia—Cisplatin—germ cell cancer	0.00058	0.0019	CcSEcCtD
Trametinib—Fatigue—Dactinomycin—germ cell cancer	0.000577	0.00189	CcSEcCtD
Trametinib—Back pain—Etoposide—germ cell cancer	0.000574	0.00188	CcSEcCtD
Trametinib—Muscle spasms—Etoposide—germ cell cancer	0.000571	0.00187	CcSEcCtD
Trametinib—Body temperature increased—Bleomycin—germ cell cancer	0.000567	0.00186	CcSEcCtD
Trametinib—Dizziness—Vinblastine—germ cell cancer	0.000562	0.00184	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000559	0.00183	CcSEcCtD
Trametinib—Myalgia—Cisplatin—germ cell cancer	0.000552	0.0018	CcSEcCtD
Trametinib—Anaemia—Etoposide—germ cell cancer	0.000549	0.00179	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000548	0.00179	CcSEcCtD
Trametinib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000547	0.00179	CcSEcCtD
Trametinib—Vomiting—Vinblastine—germ cell cancer	0.00054	0.00177	CcSEcCtD
Trametinib—Decreased appetite—Ifosfamide—germ cell cancer	0.000533	0.00174	CcSEcCtD
Trametinib—Headache—Vinblastine—germ cell cancer	0.000532	0.00174	CcSEcCtD
Trametinib—Leukopenia—Etoposide—germ cell cancer	0.000531	0.00174	CcSEcCtD
Trametinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000529	0.00173	CcSEcCtD
Trametinib—Abdominal pain—Dactinomycin—germ cell cancer	0.000529	0.00173	CcSEcCtD
Trametinib—Body temperature increased—Dactinomycin—germ cell cancer	0.000529	0.00173	CcSEcCtD
Trametinib—Fatigue—Ifosfamide—germ cell cancer	0.000529	0.00173	CcSEcCtD
Trametinib—Oedema—Cisplatin—germ cell cancer	0.000529	0.00173	CcSEcCtD
Trametinib—Infection—Cisplatin—germ cell cancer	0.000525	0.00172	CcSEcCtD
Trametinib—Constipation—Ifosfamide—germ cell cancer	0.000524	0.00172	CcSEcCtD
Trametinib—Nervous system disorder—Cisplatin—germ cell cancer	0.000518	0.0017	CcSEcCtD
Trametinib—Cough—Etoposide—germ cell cancer	0.000518	0.00169	CcSEcCtD
Trametinib—Thrombocytopenia—Cisplatin—germ cell cancer	0.000518	0.00169	CcSEcCtD
Trametinib—Asthenia—Bleomycin—germ cell cancer	0.000515	0.00168	CcSEcCtD
Trametinib—Skin disorder—Cisplatin—germ cell cancer	0.000514	0.00168	CcSEcCtD
Trametinib—Hypertension—Etoposide—germ cell cancer	0.000512	0.00168	CcSEcCtD
Trametinib—Hyperhidrosis—Cisplatin—germ cell cancer	0.000511	0.00167	CcSEcCtD
Trametinib—Pruritus—Bleomycin—germ cell cancer	0.000508	0.00166	CcSEcCtD
Trametinib—Nausea—Vinblastine—germ cell cancer	0.000505	0.00165	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000502	0.00164	CcSEcCtD
Trametinib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000501	0.00164	CcSEcCtD
Trametinib—Pancreatitis—Methotrexate—germ cell cancer	0.0005	0.00164	CcSEcCtD
Trametinib—Abdominal discomfort—Methotrexate—germ cell cancer	0.000489	0.0016	CcSEcCtD
Trametinib—Body temperature increased—Ifosfamide—germ cell cancer	0.000485	0.00159	CcSEcCtD
Trametinib—Abdominal pain—Ifosfamide—germ cell cancer	0.000485	0.00159	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000482	0.00158	CcSEcCtD
Trametinib—Infection—Etoposide—germ cell cancer	0.000481	0.00157	CcSEcCtD
Trametinib—Asthenia—Dactinomycin—germ cell cancer	0.00048	0.00157	CcSEcCtD
Trametinib—Neutropenia—Methotrexate—germ cell cancer	0.000477	0.00156	CcSEcCtD
Trametinib—Thrombocytopenia—Etoposide—germ cell cancer	0.000474	0.00155	CcSEcCtD
Trametinib—Skin disorder—Etoposide—germ cell cancer	0.00047	0.00154	CcSEcCtD
Trametinib—Hyperhidrosis—Etoposide—germ cell cancer	0.000468	0.00153	CcSEcCtD
Trametinib—Decreased appetite—Cisplatin—germ cell cancer	0.00046	0.0015	CcSEcCtD
Trametinib—Diarrhoea—Dactinomycin—germ cell cancer	0.000458	0.0015	CcSEcCtD
Trametinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000456	0.00149	CcSEcCtD
Trametinib—Vomiting—Bleomycin—germ cell cancer	0.000456	0.00149	CcSEcCtD
Trametinib—Infestation NOS—Methotrexate—germ cell cancer	0.000455	0.00149	CcSEcCtD
Trametinib—Infestation—Methotrexate—germ cell cancer	0.000455	0.00149	CcSEcCtD
Trametinib—Rash—Bleomycin—germ cell cancer	0.000452	0.00148	CcSEcCtD
Trametinib—Dermatitis—Bleomycin—germ cell cancer	0.000452	0.00148	CcSEcCtD
Trametinib—Renal failure—Methotrexate—germ cell cancer	0.000447	0.00146	CcSEcCtD
Trametinib—Stomatitis—Methotrexate—germ cell cancer	0.000443	0.00145	CcSEcCtD
Trametinib—MAP2K1—Signaling by NGF—FGF4—germ cell cancer	0.00044	0.00193	CbGpPWpGaD
Trametinib—Asthenia—Ifosfamide—germ cell cancer	0.00044	0.00144	CcSEcCtD
Trametinib—MAP2K1—TSH signaling pathway—MYC—germ cell cancer	0.000439	0.00192	CbGpPWpGaD
Trametinib—MAP2K1—IL-3 Signaling Pathway—HRAS—germ cell cancer	0.000438	0.00192	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—KIT—germ cell cancer	0.000437	0.00192	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—KIT—germ cell cancer	0.000435	0.0019	CbGpPWpGaD
Trametinib—Pruritus—Ifosfamide—germ cell cancer	0.000434	0.00142	CcSEcCtD
Trametinib—Haematuria—Methotrexate—germ cell cancer	0.000434	0.00142	CcSEcCtD
Trametinib—MAP2K2—IL2-mediated signaling events—HRAS—germ cell cancer	0.000433	0.0019	CbGpPWpGaD
Trametinib—Epistaxis—Methotrexate—germ cell cancer	0.000429	0.0014	CcSEcCtD
Trametinib—Nausea—Bleomycin—germ cell cancer	0.000426	0.00139	CcSEcCtD
Trametinib—MAP2K1—Downstream signal transduction—FGFR3—germ cell cancer	0.000426	0.00187	CbGpPWpGaD
Trametinib—Vomiting—Dactinomycin—germ cell cancer	0.000425	0.00139	CcSEcCtD
Trametinib—MAP2K1—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—germ cell cancer	0.000424	0.00186	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—FGFR3—germ cell cancer	0.000424	0.00186	CbGpPWpGaD
Trametinib—MAP2K1—ErbB Signaling Pathway—TP53—germ cell cancer	0.000423	0.00185	CbGpPWpGaD
Trametinib—Rash—Dactinomycin—germ cell cancer	0.000422	0.00138	CcSEcCtD
Trametinib—MAP2K2—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000422	0.00185	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000422	0.00185	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—FGFR3—germ cell cancer	0.000422	0.00185	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—FGFR3—germ cell cancer	0.000422	0.00185	CbGpPWpGaD
Trametinib—Decreased appetite—Etoposide—germ cell cancer	0.000421	0.00138	CcSEcCtD
Trametinib—Diarrhoea—Ifosfamide—germ cell cancer	0.00042	0.00137	CcSEcCtD
Trametinib—MAP2K1—DAP12 signaling—FGFR3—germ cell cancer	0.000419	0.00184	CbGpPWpGaD
Trametinib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000418	0.00137	CcSEcCtD
Trametinib—MAP2K2—Signaling by EGFR—FGFR3—germ cell cancer	0.000418	0.00183	CbGpPWpGaD
Trametinib—Body temperature increased—Cisplatin—germ cell cancer	0.000418	0.00137	CcSEcCtD
Trametinib—MAP2K2—Downstream signal transduction—KIT—germ cell cancer	0.000418	0.00183	CbGpPWpGaD
Trametinib—Fatigue—Etoposide—germ cell cancer	0.000418	0.00137	CcSEcCtD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.000416	0.00182	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—KIT—germ cell cancer	0.000416	0.00182	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.000414	0.00182	CbGpPWpGaD
Trametinib—Constipation—Etoposide—germ cell cancer	0.000414	0.00136	CcSEcCtD
Trametinib—MAP2K2—Developmental Biology—SOX2—germ cell cancer	0.000414	0.00181	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—KIT—germ cell cancer	0.000414	0.00181	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—FGFR3—germ cell cancer	0.000413	0.00181	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—KIT—germ cell cancer	0.000412	0.0018	CbGpPWpGaD
Trametinib—Haemoglobin—Methotrexate—germ cell cancer	0.00041	0.00134	CcSEcCtD
Trametinib—MAP2K1—Signaling by ERBB4—KIT—germ cell cancer	0.000409	0.00179	CbGpPWpGaD
Trametinib—MAP2K2—SHP2 signaling—HRAS—germ cell cancer	0.000409	0.00179	CbGpPWpGaD
Trametinib—Haemorrhage—Methotrexate—germ cell cancer	0.000408	0.00134	CcSEcCtD
Trametinib—Dizziness—Ifosfamide—germ cell cancer	0.000406	0.00133	CcSEcCtD
Trametinib—MAP2K1—IL2-mediated signaling events—HRAS—germ cell cancer	0.000405	0.00177	CbGpPWpGaD
Trametinib—MAP2K1—ErbB Signaling Pathway—HRAS—germ cell cancer	0.000405	0.00177	CbGpPWpGaD
Trametinib—Urinary tract disorder—Methotrexate—germ cell cancer	0.000403	0.00132	CcSEcCtD
Trametinib—MAP2K2—Kit receptor signaling pathway—HRAS—germ cell cancer	0.000403	0.00177	CbGpPWpGaD
Trametinib—Urethral disorder—Methotrexate—germ cell cancer	0.0004	0.00131	CcSEcCtD
Trametinib—Nausea—Dactinomycin—germ cell cancer	0.000398	0.0013	CcSEcCtD
Trametinib—Gastrointestinal pain—Etoposide—germ cell cancer	0.000396	0.0013	CcSEcCtD
Trametinib—MAP2K1—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000395	0.00173	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—FGFR3—germ cell cancer	0.000395	0.00173	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000395	0.00173	CbGpPWpGaD
Trametinib—MAP2K2—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	0.000392	0.00172	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—FGFR3—germ cell cancer	0.000391	0.00171	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—KIT—germ cell cancer	0.000391	0.00171	CbGpPWpGaD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.00039	0.00171	CbGpPWpGaD
Trametinib—Vomiting—Ifosfamide—germ cell cancer	0.00039	0.00128	CcSEcCtD
Trametinib—MAP2K1—Signaling by FGFR—KIT—germ cell cancer	0.000389	0.0017	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.000388	0.0017	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—SOX2—germ cell cancer	0.000387	0.0017	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000387	0.0017	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—KIT—germ cell cancer	0.000387	0.0017	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—KIT—germ cell cancer	0.000387	0.0017	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—KIT—germ cell cancer	0.000387	0.0017	CbGpPWpGaD
Trametinib—Rash—Ifosfamide—germ cell cancer	0.000387	0.00127	CcSEcCtD
Trametinib—MAP2K2—Signaling by NGF—KITLG—germ cell cancer	0.000387	0.00169	CbGpPWpGaD
Trametinib—Dermatitis—Ifosfamide—germ cell cancer	0.000386	0.00126	CcSEcCtD
Trametinib—MAP2K1—Signaling by PDGF—FGFR3—germ cell cancer	0.000386	0.00169	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—KIT—germ cell cancer	0.000385	0.00169	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—KIT—germ cell cancer	0.000384	0.00168	CbGpPWpGaD
Trametinib—Abdominal pain—Etoposide—germ cell cancer	0.000383	0.00125	CcSEcCtD
Trametinib—Body temperature increased—Etoposide—germ cell cancer	0.000383	0.00125	CcSEcCtD
Trametinib—MAP2K2—Endothelins—HRAS—germ cell cancer	0.000382	0.00168	CbGpPWpGaD
Trametinib—MAP2K1—SHP2 signaling—HRAS—germ cell cancer	0.000382	0.00167	CbGpPWpGaD
Trametinib—Eye disorder—Methotrexate—germ cell cancer	0.000382	0.00125	CcSEcCtD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.00038	0.00167	CbGpPWpGaD
Trametinib—Asthenia—Cisplatin—germ cell cancer	0.000379	0.00124	CcSEcCtD
Trametinib—Cardiac disorder—Methotrexate—germ cell cancer	0.000379	0.00124	CcSEcCtD
Trametinib—MAP2K2—Signaling by PDGF—KIT—germ cell cancer	0.000379	0.00166	CbGpPWpGaD
Trametinib—MAP2K1—Kit receptor signaling pathway—HRAS—germ cell cancer	0.000377	0.00165	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000374	0.00164	CbGpPWpGaD
Trametinib—MAP2K2—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000373	0.00163	CbGpPWpGaD
Trametinib—Angiopathy—Methotrexate—germ cell cancer	0.00037	0.00121	CcSEcCtD
Trametinib—MAP2K2—mTOR signaling pathway—HRAS—germ cell cancer	0.000368	0.00161	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling in naïve CD8+ T cells—HRAS—germ cell cancer	0.000368	0.00161	CbGpPWpGaD
Trametinib—Mediastinal disorder—Methotrexate—germ cell cancer	0.000368	0.0012	CcSEcCtD
Trametinib—MAP2K1—Neurotrophic factor-mediated Trk receptor signaling—HRAS—germ cell cancer	0.000367	0.00161	CbGpPWpGaD
Trametinib—MAP2K1—Fc-epsilon receptor I signaling in mast cells—HRAS—germ cell cancer	0.000367	0.00161	CbGpPWpGaD
Trametinib—Chills—Methotrexate—germ cell cancer	0.000366	0.0012	CcSEcCtD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000365	0.0016	CbGpPWpGaD
Trametinib—Nausea—Ifosfamide—germ cell cancer	0.000364	0.00119	CcSEcCtD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000362	0.00159	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—KIT—germ cell cancer	0.000362	0.00159	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—KIT—germ cell cancer	0.000362	0.00159	CbGpPWpGaD
Trametinib—Diarrhoea—Cisplatin—germ cell cancer	0.000362	0.00118	CcSEcCtD
Trametinib—MAP2K1—Signaling by NGF—KITLG—germ cell cancer	0.000362	0.00158	CbGpPWpGaD
Trametinib—MAP2K2—NCAM signaling for neurite out-growth—HRAS—germ cell cancer	0.00036	0.00158	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—KIT—germ cell cancer	0.000359	0.00157	CbGpPWpGaD
Trametinib—MAP2K1—Endothelins—HRAS—germ cell cancer	0.000358	0.00157	CbGpPWpGaD
Trametinib—Mental disorder—Methotrexate—germ cell cancer	0.000358	0.00117	CcSEcCtD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000356	0.00156	CbGpPWpGaD
Trametinib—Malnutrition—Methotrexate—germ cell cancer	0.000355	0.00116	CcSEcCtD
Trametinib—Erythema—Methotrexate—germ cell cancer	0.000355	0.00116	CcSEcCtD
Trametinib—MAP2K1—Signaling by PDGF—KIT—germ cell cancer	0.000354	0.00155	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.00035	0.00153	CbGpPWpGaD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000349	0.00153	CbGpPWpGaD
Trametinib—Dysgeusia—Methotrexate—germ cell cancer	0.000348	0.00114	CcSEcCtD
Trametinib—Asthenia—Etoposide—germ cell cancer	0.000348	0.00114	CcSEcCtD
Trametinib—MAP2K2—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000345	0.00151	CbGpPWpGaD
Trametinib—MAP2K1—TSH signaling pathway—HRAS—germ cell cancer	0.000345	0.00151	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling in naïve CD8+ T cells—HRAS—germ cell cancer	0.000345	0.00151	CbGpPWpGaD
Trametinib—MAP2K1—mTOR signaling pathway—HRAS—germ cell cancer	0.000345	0.00151	CbGpPWpGaD
Trametinib—Back pain—Methotrexate—germ cell cancer	0.000344	0.00112	CcSEcCtD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000343	0.0015	CbGpPWpGaD
Trametinib—Pruritus—Etoposide—germ cell cancer	0.000343	0.00112	CcSEcCtD
Trametinib—MAP2K1—BCR signaling pathway—HRAS—germ cell cancer	0.000341	0.00149	CbGpPWpGaD
Trametinib—MAP2K1—NCAM signaling for neurite out-growth—HRAS—germ cell cancer	0.000337	0.00147	CbGpPWpGaD
Trametinib—Vomiting—Cisplatin—germ cell cancer	0.000336	0.0011	CcSEcCtD
Trametinib—Vision blurred—Methotrexate—germ cell cancer	0.000335	0.0011	CcSEcCtD
Trametinib—Rash—Cisplatin—germ cell cancer	0.000333	0.00109	CcSEcCtD
Trametinib—Dermatitis—Cisplatin—germ cell cancer	0.000333	0.00109	CcSEcCtD
Trametinib—MAP2K2—Leptin signaling pathway—HRAS—germ cell cancer	0.000333	0.00146	CbGpPWpGaD
Trametinib—Diarrhoea—Etoposide—germ cell cancer	0.000331	0.00108	CcSEcCtD
Trametinib—Anaemia—Methotrexate—germ cell cancer	0.000329	0.00107	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—TP53—germ cell cancer	0.000324	0.00142	CbGpPWpGaD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—MYC—germ cell cancer	0.000323	0.00141	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000321	0.00141	CbGpPWpGaD
Trametinib—Dizziness—Etoposide—germ cell cancer	0.00032	0.00105	CcSEcCtD
Trametinib—Leukopenia—Methotrexate—germ cell cancer	0.000318	0.00104	CcSEcCtD
Trametinib—MAP2K2—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—germ cell cancer	0.000316	0.00138	CbGpPWpGaD
Trametinib—Nausea—Cisplatin—germ cell cancer	0.000314	0.00103	CcSEcCtD
Trametinib—MAP2K1—Leptin signaling pathway—HRAS—germ cell cancer	0.000311	0.00136	CbGpPWpGaD
Trametinib—Cough—Methotrexate—germ cell cancer	0.00031	0.00101	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—HRAS—germ cell cancer	0.00031	0.00136	CbGpPWpGaD
Trametinib—Vomiting—Etoposide—germ cell cancer	0.000308	0.00101	CcSEcCtD
Trametinib—Rash—Etoposide—germ cell cancer	0.000305	0.000999	CcSEcCtD
Trametinib—Dermatitis—Etoposide—germ cell cancer	0.000305	0.000998	CcSEcCtD
Trametinib—Headache—Etoposide—germ cell cancer	0.000303	0.000993	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—TP53—germ cell cancer	0.000303	0.00133	CbGpPWpGaD
Trametinib—Myalgia—Methotrexate—germ cell cancer	0.000303	0.00099	CcSEcCtD
Trametinib—Arthralgia—Methotrexate—germ cell cancer	0.000303	0.00099	CcSEcCtD
Trametinib—MAP2K2—IRS-mediated signalling—HRAS—germ cell cancer	0.000301	0.00132	CbGpPWpGaD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000301	0.000983	CcSEcCtD
Trametinib—MAP2K1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—germ cell cancer	0.000296	0.0013	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events—HRAS—germ cell cancer	0.000293	0.00128	CbGpPWpGaD
Trametinib—MAP2K2—IRS-related events triggered by IGF1R—HRAS—germ cell cancer	0.00029	0.00127	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—HRAS—germ cell cancer	0.00029	0.00127	CbGpPWpGaD
Trametinib—Infection—Methotrexate—germ cell cancer	0.000288	0.000943	CcSEcCtD
Trametinib—Nausea—Etoposide—germ cell cancer	0.000288	0.000941	CcSEcCtD
Trametinib—MAP2K2—TCR Signaling Pathway—HRAS—germ cell cancer	0.000288	0.00126	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—FGFR3—germ cell cancer	0.000287	0.00126	CbGpPWpGaD
Trametinib—Nervous system disorder—Methotrexate—germ cell cancer	0.000285	0.000931	CcSEcCtD
Trametinib—Thrombocytopenia—Methotrexate—germ cell cancer	0.000284	0.000929	CcSEcCtD
Trametinib—MAP2K2—Insulin receptor signalling cascade—HRAS—germ cell cancer	0.000283	0.00124	CbGpPWpGaD
Trametinib—MAP2K2—IGF1R signaling cascade—HRAS—germ cell cancer	0.000283	0.00124	CbGpPWpGaD
Trametinib—Skin disorder—Methotrexate—germ cell cancer	0.000282	0.000922	CcSEcCtD
Trametinib—MAP2K1—IRS-mediated signalling—HRAS—germ cell cancer	0.000282	0.00123	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—MYC—germ cell cancer	0.000281	0.00123	CbGpPWpGaD
Trametinib—Hyperhidrosis—Methotrexate—germ cell cancer	0.00028	0.000918	CcSEcCtD
Trametinib—MAP2K1—IRS-related events—HRAS—germ cell cancer	0.000274	0.0012	CbGpPWpGaD
Trametinib—MAP2K1—IRS-related events triggered by IGF1R—HRAS—germ cell cancer	0.000271	0.00119	CbGpPWpGaD
Trametinib—MAP2K2—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.000271	0.00119	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—MYC—germ cell cancer	0.000269	0.00118	CbGpPWpGaD
Trametinib—MAP2K1—TCR Signaling Pathway—HRAS—germ cell cancer	0.000269	0.00118	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—FGFR3—germ cell cancer	0.000269	0.00118	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGF4—germ cell cancer	0.000268	0.00118	CbGpPWpGaD
Trametinib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000264	0.000865	CcSEcCtD
Trametinib—MAP2K1—IGF1R signaling cascade—HRAS—germ cell cancer	0.000264	0.00116	CbGpPWpGaD
Trametinib—MAP2K1—Insulin receptor signalling cascade—HRAS—germ cell cancer	0.000264	0.00116	CbGpPWpGaD
Trametinib—MAP2K2—Integrin-mediated Cell Adhesion—HRAS—germ cell cancer	0.000264	0.00116	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—KIT—germ cell cancer	0.000264	0.00116	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—MYC—germ cell cancer	0.000263	0.00115	CbGpPWpGaD
Trametinib—Insomnia—Methotrexate—germ cell cancer	0.000262	0.000858	CcSEcCtD
Trametinib—MAP2K2—ErbB1 downstream signaling—HRAS—germ cell cancer	0.000254	0.00111	CbGpPWpGaD
Trametinib—MAP2K1—B Cell Receptor Signaling Pathway—HRAS—germ cell cancer	0.000253	0.00111	CbGpPWpGaD
Trametinib—Decreased appetite—Methotrexate—germ cell cancer	0.000252	0.000825	CcSEcCtD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—MYC—germ cell cancer	0.000252	0.0011	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SLC2A3—germ cell cancer	0.000251	0.0011	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGF4—germ cell cancer	0.000251	0.0011	CbGpPWpGaD
Trametinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00025	0.000819	CcSEcCtD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.00025	0.0011	CbGpPWpGaD
Trametinib—Fatigue—Methotrexate—germ cell cancer	0.00025	0.000818	CcSEcCtD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—TP53—germ cell cancer	0.000249	0.00109	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Interleukins—HRAS—germ cell cancer	0.000248	0.00109	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PVRL2—germ cell cancer	0.000247	0.00108	CbGpPWpGaD
Trametinib—MAP2K1—Integrin-mediated Cell Adhesion—HRAS—germ cell cancer	0.000247	0.00108	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—KIT—germ cell cancer	0.000247	0.00108	CbGpPWpGaD
Trametinib—MAP2K1—ErbB1 downstream signaling—HRAS—germ cell cancer	0.000238	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	0.000238	0.00104	CbGpPWpGaD
Trametinib—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000237	0.000776	CcSEcCtD
Trametinib—MAP2K2—Signaling by VEGF—HRAS—germ cell cancer	0.000236	0.00104	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SLC2A3—germ cell cancer	0.000235	0.00103	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by Insulin receptor—HRAS—germ cell cancer	0.000235	0.00103	CbGpPWpGaD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.000234	0.00103	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Interleukins—HRAS—germ cell cancer	0.000232	0.00102	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PVRL2—germ cell cancer	0.000232	0.00101	CbGpPWpGaD
Trametinib—Body temperature increased—Methotrexate—germ cell cancer	0.000229	0.00075	CcSEcCtD
Trametinib—Abdominal pain—Methotrexate—germ cell cancer	0.000229	0.00075	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—MYC—germ cell cancer	0.000222	0.000973	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—germ cell cancer	0.000221	0.00097	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—HRAS—germ cell cancer	0.000221	0.000969	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—HRAS—germ cell cancer	0.000221	0.000969	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—KITLG—germ cell cancer	0.000221	0.000966	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—HRAS—germ cell cancer	0.00022	0.000962	CbGpPWpGaD
Trametinib—Asthenia—Methotrexate—germ cell cancer	0.000208	0.000681	CcSEcCtD
Trametinib—MAP2K1—MAPK Signaling Pathway—MYC—germ cell cancer	0.000208	0.000911	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—germ cell cancer	0.000207	0.000907	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—HRAS—germ cell cancer	0.000207	0.000906	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—KITLG—germ cell cancer	0.000206	0.000904	CbGpPWpGaD
Trametinib—Pruritus—Methotrexate—germ cell cancer	0.000205	0.000672	CcSEcCtD
Trametinib—MAP2K2—Signaling by SCF-KIT—HRAS—germ cell cancer	0.000201	0.00088	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—OXT—germ cell cancer	0.0002	0.000878	CbGpPWpGaD
Trametinib—Diarrhoea—Methotrexate—germ cell cancer	0.000199	0.000649	CcSEcCtD
Trametinib—MAP2K2—BDNF signaling pathway—HRAS—germ cell cancer	0.000197	0.000865	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.000192	0.000842	CbGpPWpGaD
Trametinib—Dizziness—Methotrexate—germ cell cancer	0.000192	0.000628	CcSEcCtD
Trametinib—MAP2K2—Signaling by ERBB4—HRAS—germ cell cancer	0.000189	0.000828	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—HRAS—germ cell cancer	0.000188	0.000823	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000188	0.000822	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—OXT—germ cell cancer	0.000188	0.000822	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—HRAS—germ cell cancer	0.000185	0.000809	CbGpPWpGaD
Trametinib—Vomiting—Methotrexate—germ cell cancer	0.000184	0.000604	CcSEcCtD
Trametinib—Rash—Methotrexate—germ cell cancer	0.000183	0.000598	CcSEcCtD
Trametinib—Dermatitis—Methotrexate—germ cell cancer	0.000183	0.000598	CcSEcCtD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—germ cell cancer	0.000182	0.000799	CbGpPWpGaD
Trametinib—Headache—Methotrexate—germ cell cancer	0.000182	0.000595	CcSEcCtD
Trametinib—MAP2K2—Insulin Signaling—HRAS—germ cell cancer	0.000181	0.000795	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—HRAS—germ cell cancer	0.000181	0.000791	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.00018	0.000787	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	0.00018	0.000787	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—HRAS—germ cell cancer	0.00018	0.000787	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—HRAS—germ cell cancer	0.000179	0.000783	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000179	0.000783	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—HRAS—germ cell cancer	0.000178	0.000779	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—HRAS—germ cell cancer	0.000177	0.000775	CbGpPWpGaD
Trametinib—Nausea—Methotrexate—germ cell cancer	0.000172	0.000564	CcSEcCtD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—germ cell cancer	0.000171	0.000748	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—HRAS—germ cell cancer	0.00017	0.000744	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—HRAS—germ cell cancer	0.000169	0.00074	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—HRAS—germ cell cancer	0.000168	0.000736	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	0.000168	0.000736	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—HRAS—germ cell cancer	0.000167	0.000733	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—HRAS—germ cell cancer	0.000167	0.000733	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000167	0.000733	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—HRAS—germ cell cancer	0.000167	0.000733	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—HRAS—germ cell cancer	0.000166	0.000729	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—HRAS—germ cell cancer	0.000166	0.000727	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000164	0.00072	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—FGFR3—germ cell cancer	0.000164	0.000718	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—HRAS—germ cell cancer	0.000164	0.000717	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—HRAS—germ cell cancer	0.000158	0.000693	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—HRAS—germ cell cancer	0.000157	0.000686	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000157	0.000686	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—HRAS—germ cell cancer	0.000157	0.000686	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF4—germ cell cancer	0.000156	0.000685	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—HRAS—germ cell cancer	0.000155	0.00068	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000154	0.000675	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000154	0.000674	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FGFR3—germ cell cancer	0.000153	0.000672	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—HRAS—germ cell cancer	0.000153	0.000671	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—KIT—germ cell cancer	0.00015	0.000659	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000148	0.000649	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—HRAS—germ cell cancer	0.000148	0.000648	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF4—germ cell cancer	0.000146	0.000641	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF4—germ cell cancer	0.000144	0.000632	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000143	0.000628	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—KIT—germ cell cancer	0.000141	0.000617	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000139	0.000608	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AVP—germ cell cancer	0.000137	0.000602	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF4—germ cell cancer	0.000135	0.000592	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	0.000134	0.000587	CbGpPWpGaD
Trametinib—MAP2K2—Disease—H2AFZ—germ cell cancer	0.000129	0.000565	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AVP—germ cell cancer	0.000129	0.000563	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—KITLG—germ cell cancer	0.000128	0.000563	CbGpPWpGaD
Trametinib—MAP2K1—Disease—H2AFZ—germ cell cancer	0.000121	0.000528	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—KITLG—germ cell cancer	0.00012	0.000526	CbGpPWpGaD
Trametinib—MAP2K2—Disease—KITLG—germ cell cancer	0.000119	0.00052	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OXT—germ cell cancer	0.000118	0.000519	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HRAS—germ cell cancer	0.000116	0.000508	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—HRAS—germ cell cancer	0.000114	0.0005	CbGpPWpGaD
Trametinib—MAP2K1—Disease—KITLG—germ cell cancer	0.000111	0.000486	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OXT—germ cell cancer	0.000111	0.000485	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HRAS—germ cell cancer	0.000108	0.000475	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—HRAS—germ cell cancer	0.000107	0.000467	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—HRAS—germ cell cancer	0.000103	0.000452	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF4—germ cell cancer	0.000101	0.000443	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A3—germ cell cancer	9.91e-05	0.000434	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC22A3—germ cell cancer	9.76e-05	0.000428	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—HRAS—germ cell cancer	9.65e-05	0.000423	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGFR3—germ cell cancer	9.55e-05	0.000418	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF4—germ cell cancer	9.46e-05	0.000414	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—H2AFZ—germ cell cancer	9.03e-05	0.000395	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGFR3—germ cell cancer	8.93e-05	0.000391	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGFR3—germ cell cancer	8.81e-05	0.000386	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—KIT—germ cell cancer	8.76e-05	0.000384	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—H2AFZ—germ cell cancer	8.45e-05	0.00037	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KITLG—germ cell cancer	8.3e-05	0.000364	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGFR3—germ cell cancer	8.25e-05	0.000361	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—KIT—germ cell cancer	8.2e-05	0.000359	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AVP—germ cell cancer	8.12e-05	0.000356	CbGpPWpGaD
Trametinib—MAP2K2—Disease—KIT—germ cell cancer	8.09e-05	0.000355	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CRABP1—germ cell cancer	7.96e-05	0.000349	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KITLG—germ cell cancer	7.77e-05	0.00034	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AVP—germ cell cancer	7.59e-05	0.000333	CbGpPWpGaD
Trametinib—MAP2K1—Disease—KIT—germ cell cancer	7.57e-05	0.000332	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HRAS—germ cell cancer	7.36e-05	0.000323	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HRAS—germ cell cancer	6.89e-05	0.000302	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—HRAS—germ cell cancer	6.5e-05	0.000285	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGFR3—germ cell cancer	6.17e-05	0.00027	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—HRAS—germ cell cancer	6.08e-05	0.000267	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGFR3—germ cell cancer	5.77e-05	0.000253	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—KIT—germ cell cancer	5.67e-05	0.000248	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	5.32e-05	0.000233	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KIT—germ cell cancer	5.3e-05	0.000232	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	5.24e-05	0.00023	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MYC—germ cell cancer	4.45e-05	0.000195	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	4.27e-05	0.000187	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MYC—germ cell cancer	4.17e-05	0.000183	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HRAS—germ cell cancer	4.15e-05	0.000182	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HRAS—germ cell cancer	3.88e-05	0.00017	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HRAS—germ cell cancer	3.79e-05	0.000166	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HRAS—germ cell cancer	3.54e-05	0.000155	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HRAS—germ cell cancer	3.5e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HRAS—germ cell cancer	3.27e-05	0.000143	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MYC—germ cell cancer	3.12e-05	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MYC—germ cell cancer	2.92e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—germ cell cancer	2.56e-05	0.000112	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HRAS—germ cell cancer	2.45e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—germ cell cancer	2.4e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HRAS—germ cell cancer	2.29e-05	0.0001	CbGpPWpGaD
